Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Postmenopausal Osteoporosis Treatment Market?
The market for treating postmenopausal osteoporosis has experienced steady growth recently. It’s projected to increase from $10.1 billion in 2024 to $10.54 billion in 2025, marking a compound annual growth rate (CAGR) of 4.4%. Factors contributing to growth during this historical period include an aging population, the advent of hormone replacement therapy, heightened awareness, the ability to minimize the risk of fractures, and the use of nutritional supplements.
Expectations are high for significant expansion in the postmenopausal osteoporosis treatment market in the upcoming years. The market is forecasted to elevate to $13.38 billion in 2029, posting a compound annual growth rate (CAGR) of 6.1%. The projected growth during this period can be credited to factors such as the advancement in healthcare infrastructure, amplified screening programs, the application of precise medicine, the implementation of biosimilars in osteoporosis treatment, and the focus on bone health in women’s health issues. The incorporation of digital health and the introduction of regenerative medicine approaches also contribute. The forecasted period will witness trends such as enhancements in diagnosis, the creation of new drugs, the rise of new therapies and collaborative efforts in drug development, and the inclusion of artificial intelligence.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12680&type=smp
What Drivers Are Accelerating Expansion Of The Postmenopausal Osteoporosis Treatment Market?
The growing presence of osteoporosis is anticipated to fuel the expansion of the postmenopausal osteoporosis treatment market. Osteoporosis, a medical condition characterized by a reduction in bone density and compromised bone tissue, heightens vulnerability and the risk of fractures. Treatments for postmenopausal osteoporosis aim to prevent or control this disease, reducing fracture risks and enhancing the overall quality of life for sufferers. For example, Healthy Bones Australia, a non-governmental organization, reported in September 2022 that the incidences of fractures due to osteoporosis or osteopenia rose from 178,439 in 2021 to 183,105 in 2022. As such, the growing occurrence of osteoporosis is fueling the expansion of the postmenopausal osteoporosis treatment market.
What Are The Key Segment Trends Observed In The Postmenopausal Osteoporosis Treatment Market?
The postmenopausal osteoporosis treatmentmarket covered in this report is segmented –
1) By Drug Type: Bisphosphonates; Vitamin D3; Estrogen Agonist Or Antagonist; Hormone Replacement Therapy; Parathyroid Hormone Therapy; Other Drug Types
2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Bisphosphonates: Alendronate; Risedronate; Zoledronic Acid
2) By Vitamin D3: Cholecalciferol; Ergocalciferol
3) By Estrogen Agonist Or Antagonist: Selective Estrogen Receptor Modulators (SERMs); Tamoxifen
4) By Hormone Replacement Therapy: Estrogen Therapy; Combined Estrogen-Progestin Therapy
5) By Parathyroid Hormone Therapy: Teriparatide; Abaloparatide
6) By Other Drug Types: Calcitonin; RANK Ligand Inhibitors
Which Disruptive Trends Are Driving Change Across The Postmenopausal Osteoporosis Treatment Market?
The trend of product innovations is becoming increasingly prevalent in the postmenopausal osteoporosis treatment market. The primary corporations within this market are concentrating on the advent of innovative products like parathyroid hormone, in order to achieve more effective results and patient compliance. They are investigating the potential of combined treatments and personalized medicine to improve patient outcomes. Furthermore, they place a high value on comprehensive safety studies and patient support programs to alleviate concerns and encourage adherence. Parathyroid hormone (PTH), a hormone made by the parathyroid glands, is responsible for controlling blood calcium levels. This includes stimulating the release of calcium from bones, enhancing kidney reabsorption, and triggering vitamin D to increase intestinal calcium absorption. As an illustration, Apotex Corp., a pharmaceutical corporation hailing from Canada, introduced a teriparatide in November 2023. This recombinant parathyroid hormone is renowned for substantially enriching bone mineral density and lowering the chance of fractures in those diagnosed with osteoporosis. Its anabolic effect boosts bone production, rendering it a crucial solution for patients at high risk.
Who Are The Major Stakeholders Operating In The Postmenopausal Osteoporosis Treatment Market?
Major companies operating in the postmenopausal osteoporosis treatment market include Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Fresenius Kabi AG, Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr.Reddys Laboratories Ltd., Hikma Pharmaceuticals PLC., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Takeda Pharmaceutical Company Limited, Lupin Limited, Ligand Pharmaceuticals Incorporated, Torrent Pharmaceuticals Limited.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Postmenopausal Osteoporosis Treatment Market?
North America was the largest region in the postmenopausal osteoporosis treatment market in 2024. The regions covered in the postmenopausal osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12680&type=smp
Browse Through More Reports Similar to the Global Postmenopausal Osteoporosis Treatment Market 2025, By The Business Research Company
Osteoporosis Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report
Osteoporosis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
Inflammatory Bowel Disease Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model